Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
了解更多
The Faces of Luminex: Jen Dillman, Product Development
There are a lot of steps between having the idea for a new product and actually making the product for commercial release. Here at Luminex, we count on people like Jen Dillman, Senior Manager of Product Development, to help get new products across the finish line.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
March 5
Luminex Corporation to Present at the Barclays Global Healthcare Conference
February 8
Luminex Corporation Declares First Quarter Cash Dividend
February 4
Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results
January 2
Luminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry Portfolio
November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results
Immunology 2019
May 9-13
San Diego, CA
Clinical Virology Symposium (CVS)
May 5-8
Savannah, GA
APHL Annual Meeting
June 3-6
St. Louis, MO
